Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.
Mohammadreza ShalbafanFarzaneh MalekpourBorna Tadayon NajafabadiKiandokht GhamariSeyed-Ali DastgheibArash MowlaElham ShiraziMehrdad Eftekhar ArdebiliMaryam Ghazizadeh-HashemiShahin AkhondzadehPublished in: Journal of psychopharmacology (Oxford, England) (2019)
This trial showed a significant efficacy for tropisetron over placebo in treatment of obsessive-compulsive disorder symptoms when added to fluvoxamine.
Keyphrases
- obsessive compulsive disorder
- combination therapy
- deep brain stimulation
- double blind
- end stage renal disease
- phase iii
- placebo controlled
- ejection fraction
- study protocol
- chronic kidney disease
- clinical trial
- newly diagnosed
- phase ii
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- radiation therapy
- open label
- physical activity
- rectal cancer